Phosphate-sensing and regulatory mechanism of FGF23 production
Abstract
Background Inorganic phosphate (Pi) is an essential mineral for human. Hypophosphatemia and hyperphosphatemia cause rickets/osteomalacia and ectopic calcification, respectively, indicating that serum Pi level needs to be regulated. Fibroblast growth factor (FGF) 23 is a principal hormone to regulate serum Pi level. FGF23 is produced by the bone, especially by the osteoblasts and osteocytes, and works by binding to FGF receptor (FGFR) 1c and α-Klotho complex in the kidney. FGF23 reduces serum Pi level by inhibiting both renal phosphate reabsorption and intestinal phosphate absorption via reduction of serum 1,25-dihydroxyvitamin D level. It has been unclear how the bone senses changes of serum Pi level and how the bone regulates the production of FGF23.Recent findings Our recent results indicate that the post-translational modification of FGF23 protein through a gene product of GALNT3 is the main regulatory mechanism of enhanced FGF23 production by high dietary Pi. Furthermore, high extracellular Pi directly activates FGFR1 and its downstream intracellular signaling pathway regulates the expression level of GALNT3.Conclusions We propose that FGFR1 works as a Pi-sensing receptor in the regulation of FGF23 production and serum Pi level. There is a negative feedback system, which is a basic mechanism of endocrine regulation, in the regulation of serum Pi involving FGFR1, and FGF23. These findings may lead to the development of new therapeutic methods to treat diseases caused by abnormal Pi level.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The phosphate-sensing mechanism in osteocytes may involve the activation of FGFR1 and high-affinity Na+-Pi cotransporters.
“However, as has been previously discussed,105 the phosphate-sensing mechanism in osteocytes may involve the activation of FGFR1 and high-affinity Na+-Pi cotransporters.”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [105]
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works
Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid
Brown, E. M., Gamba, G., Riccardi, D., Lombardi, M. J., Butters, R. R., Kifor, O., Sun, A. M., Hediger, M. A., Lytton, J., & Hébert, S. (1993) · Nature · doi:10.1038/366575a0 · Cited by 2,635 · see citing works
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050 · see citing works
FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S., & Yamashita, T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301264 · Cited by 1,883 · see citing works
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,846 · see citing works
Self-citationAutosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467 · see citing works
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
Jono, S., McKee, M. D., Murry, C. E., Shioi, A., Nishizawà, Y., Mori, K., Morii, H., & Giachelli, C. M. (2000) · Circulation Research · doi:10.1161/01.res.87.7.e10 · Cited by 1,425 · see citing works
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.101545198 · Cited by 1,391 · see citing works
Self-citationRegulation of Fibroblast Growth Factor-23 Signaling by Klotho*
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K., Baum, M., Schiavi, S., Hu, M.-C., Moe, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,356 · see citing works
Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1905 · Cited by 1,199 · see citing works
Evolution of the Fgf and Fgfr gene families.
Itoh, N., & Ornitz, D. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.007 · Cited by 1,123 · see citing works
Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., & Tabak, L. A. (2012) · Glycobiology · doi:10.1093/glycob/cwr182 · Cited by 876 · see citing works
Integrating signals from RTKs to ERK/MAPK
Mckay, M., & Morrison, D. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210394 · Cited by 616 · see citing works
Topaz, O., Shurman, D. L., Bergman, R., Indelman, M., Ratajczak, P., Mizrachi-Koren, M., Khamaysi, Z., Behar, D. M., Petronius, D., Friedman, V., et al. (2004) · Nature Genetics · doi:10.1038/ng1358 · Cited by 591 · see citing works
Exploring mechanisms of FGF signalling through the lens of structural biology
Goetz, R., & Mohammadi, M. (2013) · Nature reviews. Molecular cell biology · doi:10.1038/nrm3528 · Cited by 556 · see citing works
Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 553 · see citing works
Phosphate is a specific signal for induction of osteopontin gene expression
Beck, G. R., Zerler, B. R., & Morán, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140021997 · Cited by 533 · see citing works
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518 · see citing works
Pathogenic role of Fgf23 in Hyp mice
Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., & Quarles, L. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2006 · Cited by 494 · see citing works
α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
Chen, G., Yang, L., Goetz, R. M., Fu, L., Jayaraman, S., Hu, M. C., Moe, O. W., Liang, G., Li, X., & Mohammadi, M. (2018) · Nature · doi:10.1038/nature25451 · Cited by 491 · see citing works
Guagnano, V., Furet, P., Spanka, C., Bordas, V., Douget, M. L., Stamm, C., Brueggen, J., Jensen, M. R., Schnell, C., SCHMID, H. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2006222 · Cited by 485 · see citing works
Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo
Saitô, H., Maeda, A., Ohtomo, S., Hirata, M., Kusano, K., Kato, S., Ogata, E., Segawa, H., Miyamoto, K., & Fukushima, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408903200 · Cited by 468 · see citing works
Shimada, T., Muto, T., Urakawa, I., Yoneya, T., Yamazaki, Y., Okawa, K., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2002) · Endocrinology · doi:10.1210/endo.143.8.8795 · Cited by 439 · see citing works
Self-citationPerwad, F., Azam, N., Zhang, M. Y. H., Yamashita, T., Tenenhouse, H. S., & Portale, A. A. (2005) · Endocrinology · doi:10.1210/en.2005-0777 · Cited by 424 · see citing works
Farrow, E., Yu, X., Summers, L. J., Davis, S. I., Fleet, J. C., Allen, M. R., Robling, A. G., Stayrook, K. R., Jideonwo, V. N., Magers, M. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110905108 · Cited by 380 · see citing works
Tagliabracci, V. S., Engel, J. D., Wiley, S. E., Xiao, J., Gonzalez, D. J., Appaiah, H. N., Koller, A. A., Nizet, V., White, K. E., & Dixon, J. E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402218111 · Cited by 329 · see citing works
Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.
White, K., Cabral, J., Davis, S. I., Fishburn, T., Evans, W. E., Ichikawa, S., Fields, J., Yu, X.-J., Shaw, N., McLellan, N., et al. (2005) · American Journal of Human Genetics · doi:10.1086/427956 · Cited by 320 · see citing works
Fukumoto, S., & Martin, T. J. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.02.001 · Cited by 311 · see citing works
Self-citationImel, E. A., Peacock, M., Gray, A. K., Padgett, L. R., Hui, S. L., & Econs, M. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1239 · Cited by 305 · see citing works
Phosphate transporters: a tale of two solute carrier families
Virkki, L. V., Biber, J., Murer, H., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00228.2007 · Cited by 262 · see citing works
Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction.
Furdui, C., Lew, E., Schlessinger, J., & Anderson, K. (2006) · Molecules and Cells · doi:10.1016/j.molcel.2006.01.022 · Cited by 259 · see citing works
Phosphate as a Signaling Molecule and Its Sensing Mechanism
Michigami, T., Kawai, M., Yamazaki, M., & Ozono, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00022.2017 · Cited by 181 · see citing works
Beck, G. R., & Knecht, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304470200 · Cited by 180 · see citing works
Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
Ito, N., Wijenayaka, A. R., Prideaux, M., Kogawa, M., Ormsby, R. T., Evdokiou, A., Bonewald, L. F., Findlay, D. M., & Atkins, G. J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.10.007 · Cited by 169 · see citing works
Lew, E., Furdui, C., Anderson, K., & Schlessinger, J. (2009) · Science Signaling · doi:10.1126/scisignal.2000021 · Cited by 163 · see citing works
Frishberg, Y., Ito, N., Rinat, C., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061105 · Cited by 163 · see citing works
Takashi, Y., Kosako, H., Sawatsubashi, S., Kinoshita, Y., Ito, N., Tsoumpra, M. K., Nangaku, M., Abe, M., Matsuhisa, M., Kato, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815166116 · Cited by 149 · see citing works
Self-citationX-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
Kinoshita, Y., & Fukumoto, S. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00220 · Cited by 148 · see citing works
Self-citationBon, N., Couasnay, G., Bourgine, A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807339 · Cited by 112 · see citing works
Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2
Bon, N., Frangi, G., Sourice, S., Guicheux, J., Beck-Cormier, S., & Beck, L. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.02.007 · Cited by 87 · see citing works
Yamazaki, M., Ozono, K., Okada, T., Tachikawa, K., Kondou, H., Ohata, Y., & Michigami, T. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22842 · Cited by 82 · see citing works
Kimata, M., Michigami, T., Tachikawa, K., et al. (2010) · Bone · doi:10.1016/j.bone.2010.08.006 · Cited by 82 · see citing works
Small Molecule Inhibitors of Mucin-Type O-Linked Glycosylation from a Uridine-Based Library
Hang, H. C., Yu, C., Hagen, K. G. T., Tian, E., Winans, K. A., Tabak, L. A., & Bertozzi, C. R. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.023 · Cited by 72 · see citing works
FGF23 beyond Phosphotropic Hormone
Takashi, Y., & Fukumoto, S. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.08.006 · Cited by 58 · see citing works
Self-citationNishino, J., Yamazaki, M., Kawai, M., Tachikawa, K., Yamamoto, K., Miyagawa, K., Kogo, M., Ozono, K., & Michigami, T. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25742 · Cited by 55 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works
FGF23 signalling and physiology
Ho, B. B., & Bergwitz, C. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0178 · Cited by 180 · see citing works
- Authors
- Takashi, Y., & Fukumoto, S.
- Affiliations
- Fukuoka University (JP)
- Institute of Advanced Medical Sciences, Tokushima University (JP)
- Corresponding author
- Fukumoto, S.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2020-03-05
- Volume
- 43
- Issue
- 7
- Pages
- 877-883
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W3009699402
- Cited by
- 42
- References
- 45
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 4 · 2022: 14 · 2021: 11 · 2020: 7
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (18K15980, 19H03676)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- fibroblast growth factor 23, inorganic phosphate, phosphate sensing, FGFR1, GALNT3, post-translational modification, bone, osteoblasts, osteocytes, renal phosphate reabsorption, intestinal phosphate absorption, 1,25-dihydroxyvitamin D, negative feedback, hyperphosphatemia, hypophosphatemia
- MeSH terms
- Fibroblast Growth Factor-23, Polypeptide N-acetylgalactosaminyltransferase, Animals, Bone and Bones, Fibroblast Growth Factors, Homeostasis, Humans, Kidney, Phosphates, Vitamin D, Signal Transduction, N-Acetylgalactosaminyltransferases, Receptor, Fibroblast Growth Factor, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review